These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 1655353

  • 1. The influence of adrenoreactive preparations on clinical and haemodynamic parameters in patients with ischaemic heart disease.
    Piatak OA, Yanovskii GV, Lizogub VG.
    Cor Vasa; 1991; 33(1):19-25. PubMed ID: 1655353
    [Abstract] [Full Text] [Related]

  • 2. [Mechanisms of the hemodynamic effects of nonachlazine in ischemic heart disease patients].
    Zaslavskaia RM, Zolotaia RD, Olevskiĭ IKh, Duda SG, Vilkovyskiĭ FA.
    Farmakol Toksikol; 1986; 49(6):73-7. PubMed ID: 3817152
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Mechanisms of the inotropic action of nonachlazine].
    Kaverina NV, Katsenovich RA, Tkachenko BI, Iunusov ZZ, Ovsiannikov VI.
    Farmakol Toksikol; 1985; 48(1):23-7. PubMed ID: 3979531
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of clinical effects of propranolol (Inderal) with once daily slow-release oxprenolol (Slow Trasicor) in angina pectoris.
    Majid PA, de Feijter PJ, Wardeh R, van der Wall EE, Roos JP.
    J Int Med Res; 1979; 7(3):194-200. PubMed ID: 378729
    [Abstract] [Full Text] [Related]

  • 7. The effect of double dose of omeprazole on the course of angina pectoris and treadmill stress test in patients with coronary artery disease--a randomised, double-blind, placebo controlled, crossover trial.
    Budzyński J, Kłopocka M, Pulkowski G, Suppan K, Fabisiak J, Majer M, Swiatkowski M.
    Int J Cardiol; 2008 Jul 04; 127(2):233-9. PubMed ID: 17689732
    [Abstract] [Full Text] [Related]

  • 8. [The relation between myocardial oxygen consumption and ischemia during exertion in patients with angina pectoris: effect of propranolol].
    Galvani M, Bugiardini R, Ferrini D, Gridelli C, Mari L, Pozzati A, Ferramosca B, Puddu P.
    G Ital Cardiol; 1985 Nov 04; 15(11):1032-8. PubMed ID: 3007250
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Problems in selecting the optimal propranolol dose in treating patients with angina pectoris of effort and the comparative effectiveness of inderal, anaprilin and obzidan].
    Romakov AIu, Mazur NA.
    Ter Arkh; 1984 Nov 04; 56(9):41-6. PubMed ID: 6515546
    [Abstract] [Full Text] [Related]

  • 12. [Double-blind, placebo-controlled trial of propranolol vs celiprolol in stable effort angina: antianginal efficacy and side effects ].
    Klein W, Fluch N, Brandt D.
    Wien Klin Wochenschr; 1982 May 14; 94(10):258-61. PubMed ID: 6126961
    [Abstract] [Full Text] [Related]

  • 13. Comparative study of the effects of penbutolol and propranolol in the treatment of angina pectoris.
    Hillis WS, Tweddel AC, Murray RG, Lawrie TD.
    Arzneimittelforschung; 1980 May 14; 30(9):1595-9. PubMed ID: 7006619
    [Abstract] [Full Text] [Related]

  • 14. Long-term stability of heart rate variability in chronic stable angina pectoris, and the impact of an acute myocardial infarction.
    Björkander I, Forslund L, Ericson M, Rehnqvist N, Hjemdahl P, Kahan T.
    Clin Physiol Funct Imaging; 2009 May 14; 29(3):201-8. PubMed ID: 19254330
    [Abstract] [Full Text] [Related]

  • 15. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K, Bestehorn HP, Roskamm H.
    J Cardiovasc Pharmacol; 1990 May 14; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The role of reduction of the heart rate in the favorable effect of the beta blockers on myocardial ischemia due to isoprenalin in patients with angina pectoris].
    Rivier JL, Monti M, Mazzoni S, Reymond C, Jaggi CP, Jaeger M.
    Schweiz Med Wochenschr; 1977 Nov 05; 107(44):1555-6. PubMed ID: 918610
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Activation and inhibition of adrenergic effects on the coronary vessels of patients with different forms of angina pectoris].
    De Cesare N, Bartorelli A, Fabbiocchi F, Loaldi A, Montorsi P, Cozzi S, Polese A, Guazzi MD.
    Cardiologia; 1989 Jul 05; 34(7):599-607. PubMed ID: 2551500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.